Inhibition of bleomycin-induced toxic effects by antioxidants in human malignant melanoma cells.
Kappus
H
H
Department of Dermatology, Rudolf-Virchow-Clinic Free University of Berlin, F.R.G.
Reinhold
C
C
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology; D000975:Antioxidants / Q000494:pharmacology*; D001393:Azoles / Q000494:pharmacology; D001761:Bleomycin / Q000037:antagonists & inhibitors* / Q000633:toxicity; D005260:Female; D006801:Humans; D054833:Isoindoles; D008545:Melanoma / Q000503:physiopathology*; D016566:Organoselenium Compounds; D011435:Propyl Gallate / Q000494:pharmacology; D011748:Pyrogallol / Q000494:pharmacology; D012643:Selenium / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000187:drug effects*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000975:Antioxidants; D001393:Azoles; D054833:Isoindoles; D016566:Organoselenium Compounds; D011748:Pyrogallol; D001761:Bleomycin; C042986:ebselen; D011435:Propyl Gallate; D012643:Selenium